Pfizer plans $3.5B in cost cuts as sales of Covid products continue to slide
Published
Pfizer confirmed late Friday that it will launch a company-wide cost-cutting program this year and next as sales of the drugmaker’s Covid vaccine and antiviral slide. The announcement came as the US government and the drugmaker on Friday afternoon revised terms of their…
#covidvaccine #unlock